Novolog (Pharm-Up 1966) Ltd reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was ILS 420.78 million compared to ILS 387.74 million a year ago. Net income was ILS 0.332 million compared to ILS 9.96 million a year ago. Basic earnings per share from continuing operations was ILS 0.001 compared to ILS 0.02 a year ago. Diluted earnings per share from continuing operations was ILS 0.001 compared to ILS 0.019 a year ago.
For the nine months, sales was ILS 1,247.04 million compared to ILS 1,124.5 million a year ago. Net income was ILS 1.53 million compared to ILS 33.81 million a year ago. Basic earnings per share from continuing operations was ILS 0.003 compared to ILS 0.067 a year ago. Diluted earnings per share from continuing operations was ILS 0.003 compared to ILS 0.066 a year ago.